English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The results of phase I clinical trials for the pharmacokinetic parameters of new original antituberculosis drug thiozonide in 100 mg capsules developed at the Farm-Sintez Co. (Moscow) are presented. The drag pharmacokinetics has been studied after single administration in increasing doses on various groups of healthy volunteers.

Фармакокинетическое исследование инновационного противотуберкулезного препарата тиозонида в плазме крови